Latest AI and machine learning research in parkinson's disease for healthcare professionals.
Parkinson's disease (PD) is a neurodegenerative disorder that occurs as a result of a decrease in the chemical called dopamine in the brain. There is no definitive treatment for PD, but some medications used to control symptoms in the early stages have a critical effect on the progression of the disease. Approximately 90% of patients with PD have vocal problems, and although voice disorders seen i...
Although there are notable structural abnormalities in the brain associated with psychotic diseases, it is still unclear how these abnormalities relate to clinical presentation. However, the fractal dimension (FD), which offers details on the complexity and irregularity of brain microstructures, may be a promising feature, as demonstrated by neuropsychiatric disorders such as Parkinson's and Alzhe...
Previous resting state functional MRI (rs-fMRI) analyses of the basal ganglia in Parkinson's disease heavily relied on T1-weighted imaging (T1WI) atla...
Recent advancements in diffusion generative models significantly advanced image, video, and 3D content creation from user-provided text prompts. How...
Deep learning (DL) methods are increasingly outperforming classical approaches in brain imaging, yet their generalizability across diverse imaging c...
Deep brain stimulation (DBS) is an advanced surgical treatment for the symptoms of Parkinson's disease (PD), involving electrical stimulation of neu...
Large language models (LLMs) are often constrained by rigid reasoning processes, limiting their ability to generate creative and diverse responses. ...
BACKGROUND: Despite prior studies on early-stage Parkinson's disease (PD) brain connectivity and temporal patterns, differences between tremor-dominan...
Freezing of gait (FoG) is a special symptom found in patients with Parkinson's disease (PD). Patients who have FoG abruptly lose the capacity to wal...
The leucine-rich repeat kinase 2 (LRRK2) is the most mutated gene in familial Parkinson's disease, and its mutations lead to pathogenic hallmarks of t...
Dysfunctions of the dopamine D2 and D3 receptors (D2 and D3) are implicated in neuropsychiatric conditions such as Parkinson's disease, schizophrenia,...
Speech impairments are prevalent biomarkers for Parkinson's Disease (PD), motivating the development of diagnostic techniques using speech data for ...
OBJECTIVES: Late-life depression often overlaps with neurodegenerative diseases leading to diagnostic and treatment challenges for neuropsychiatrists....
Neural networks are responsible for processing sensory stimuli and driving the synaptic activity required for brain function and behavior. This comput...
Parkinson's disease (PD) is characterised by a complex array of motor, psychiatric, and gastrointestinal symptoms, many of which are linked to disrupt...
Freezing of gait (FoG) is a debilitating symptom of Parkinson's disease that severely impacts patients' mobility and quality of life. To minimize the ...
Among the symptoms that can occur in Parkinson's disease (PD), Freezing of Gait (FOG) is a disabling phenomenon affecting a large proportion of patien...
BACKGROUND: Treatment for essential tremor (ET) and cortical myoclonus (CM) differs. As their clinical distinction can be difficult, with large inter-...
Recent advancements have shown that the Mixture of Experts (MoE) approach significantly enhances the capacity of large language models (LLMs) and im...
Parkinson's Disease (PD) is a neurodegenerative disorder that significantly impacts motor and non-motor functions. There is currently no treatment t...